Why I like these 3 small-cap healthcare shares

One area of the market that I am especially bullish on in the long-term is the healthcare sector.

This is because a combination of factors including ageing populations, increased chronic disease burden, and better treatment options, could potentially lead to strong demand for healthcare services over the next decade or two.

This could be great news for these three small-cap shares:

1300 Smiles Limited (ASX: ONT)

I think it is fair to say that conditions in the dental industry are reasonably tough at the moment. The Australian Dental Association of Queensland recently confirmed that 65% of the population do not visit the dentist for their two-yearly check-ups. However, 1300 Smiles has taken this opportunity to expand its network through acquisitions at attractive prices. I believe this has positioned it well for growth when conditions improve. Investors may, however, want to hold out for its half-year results next month before investing.

Bioxyne Ltd (ASX: BXN)

This life sciences and health products company recently launched three health and wellness products into the lucrative South East Asia market. I believe one of these products in particular has a lot of potential in a market that is becoming increasingly health-conscious. The company’s BK18 dairy-based nutritional health drink includes an immune boosting probiotic and a range of key vitamins. Initial orders have been strong ahead of the launch of its marketing campaign.

Zenitas Healthcare Ltd (ASX: ZNT)

One of my favourite small-cap shares on the ASX is Zenitas Healthcare. The home care and health services company listed on the ASX last year and has already caught the eye of a number of fund managers including WAM Microcap Ord (ASX: WMI). I don’t think it is hard to see why WAM has taken a liking to Zenitas. With the National Healthcare Reform aiming to push the burden of healthcare services from hospitals into primary care, Zenitas is in a great position to profit.

If you like small-cap shares then I think you'll love these exciting and revolutionary Aussie shares.

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Cochlear or REA Group.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended 1300SMILES Limited and Zenitas Healthcare Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!